RENAL DOPAMINE RECEPTOR FUNCTION IN OBESE ZUCKER RATS

肥胖 Zucker 大鼠肾多巴胺受体功能

基本信息

  • 批准号:
    6707999
  • 负责人:
  • 金额:
    $ 21.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-03-01 至 2006-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Verbatim from the application): Dopamine and D1-like receptors in the proximal tubules and other regions of the nephron play an important role in regulating renal sodium excretion. A defective DIA receptor (a D1-like receptor) function is reported in the proximal tubules of hepertensive animals and humans. In our preliminary studies we found that D1-Iike receptors are reduced by 50 percent and dopamine was unable to stimulate second messengers (cAMP and IP3) and thereby failed to inhibit Na,K-ATPase and Na,H-exchanger in the proximal tubules of obese Zucker rats (12 week old). Therefore, it is hypothesized that the diminished inhibitory effect of dopamine on sodium transporting proteins in the proximal tubules is due to a dysfunction in DIA receptor which results from altered phosphorylation of membranal DIA receptor as well as impaired recruitment of newer D1A receptors from cytosol. Such a defect in dopamine receptor function contributes to the diminished natriuretic response to exogenously administered as well as endogenously produced dopamine. This hypothesis will be tested by conducting a series of experiments to identify the biochemical/molecular mechanism(s) contributing towards the defect in DIA receptors. These will include: measurement of D1A receptor agonist affinity, determination of the effect of GTPyS on ligand binding, determination of agonist-dependent and -independent phosphorylation of D1A receptor, determination of agonist recmitment of D1A receptors on the membrane and measurement of D1A receptor mRNA and DIA receptor protein content in proximal tubules of lean and obese rats. The functional consequence of the defective DIA receptor function will be examined by studying the natriuretic and diuretic effect of dopamine and SKF38393 as well as by determining the effect of acute volume expansion on renal production of dopamine and sodium and water excretion in anesthetized lean and obese Zucker rats. In order to delineate the role of hyperinsulinemia in causing the defective D1A receptor function and the natriuretic response, experiments described above will also be performed in lean and obese rats (7-8 weeks) treated for four weeks with darglitazone, a drug which decreases insulin levels and improve insulin sensitivity as well as in 3-4 week old non-treated hyperinsulinemic and control rats. Identification of the mechanism(s) leading to dopamine receptor dysfunction and the diminished natriuretic response to dopamine would allow us to better understand the relationship between kidney D1A receptor function and hyperinsulinemia in obese rats.
描述(来自应用程序):多巴胺和d1样受体

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dopamine recruits D1A receptors to Na-K-ATPase-rich caveolar plasma membranes in rat renal proximal tubules.
多巴胺将 D1A 受体募集到大鼠肾近曲小管中富含 Na-K-ATP 酶的细胞膜穴质膜上。
Dopamine fails to inhibit Na,H-exchanger in proximal tubules of obese Zucker rats.
多巴胺不能抑制肥胖 Zucker 大鼠近端肾小管中的 Na,H 交换器。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mustafa F. Lokhandwala其他文献

Influence of Felodipine and Verapamil on the Sympathetic Transmitter Release and on the Pre- and Post-Junctional Effects of Exogenous Noradrenaline in the Perfused Rat Kidney
  • DOI:
    10.2165/00003495-198500292-00035
  • 发表时间:
    1985-01-01
  • 期刊:
  • 影响因子:
    14.400
  • 作者:
    Eno J. Peter;Marie L. Steenberg;Mustafa F. Lokhandwala;Bhagavan S. Jandhyala;Douglas C. Eikenburg
  • 通讯作者:
    Douglas C. Eikenburg
Central α-Adrenergic Control of Blood Pressure: Effects of Clonidine Withdrawal
  • DOI:
    10.1378/chest.83.2.328
  • 发表时间:
    1983-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Steven J. Augustine;Shiro Tachikawa;Mustafa F. Lokhandwala;Joseph P. Buckley
  • 通讯作者:
    Joseph P. Buckley
Central α-Adrenergic Control of Blood Pressure: Effects of Clonidine Withdrawal
  • DOI:
    10.1378/chest.83.2_supplement.328
  • 发表时间:
    1983-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Steven J. Augustine;Shiro Tachikawa;Mustafa F. Lokhandwala;Joseph P. Buckley
  • 通讯作者:
    Joseph P. Buckley
Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and β2 adrenoceptor agonist
  • DOI:
    10.1007/bf00175033
  • 发表时间:
    1994-09-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Severina M. Jacinto;Mustafa F. Lokhandwala;Bhagavan S. Jandhyala
  • 通讯作者:
    Bhagavan S. Jandhyala

Mustafa F. Lokhandwala的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mustafa F. Lokhandwala', 18)}}的其他基金

Transcriptional regulation of renal dopamine D1 receptors in hypertension during
高血压期间肾脏多巴胺 D1 受体的转录调控
  • 批准号:
    8881163
  • 财政年份:
    2013
  • 资助金额:
    $ 21.02万
  • 项目类别:
Transcriptional regulation: renal dopamine D1 receptors in HTN & oxidative stress
转录调控:HTN 中的肾多巴胺 D1 受体
  • 批准号:
    8577204
  • 财政年份:
    2013
  • 资助金额:
    $ 21.02万
  • 项目类别:
Transcriptional regulation of renal dopamine D1 receptors in hypertension during
高血压期间肾脏多巴胺 D1 受体的转录调控
  • 批准号:
    9098451
  • 财政年份:
    2013
  • 资助金额:
    $ 21.02万
  • 项目类别:
Age-Related Changes in Renal Dopamine Receptor Function
肾多巴胺受体功能与年龄相关的变化
  • 批准号:
    7473941
  • 财政年份:
    2005
  • 资助金额:
    $ 21.02万
  • 项目类别:
Age-Related Changes in Renal Dopamine Receptor Function
肾多巴胺受体功能与年龄相关的变化
  • 批准号:
    7097261
  • 财政年份:
    2005
  • 资助金额:
    $ 21.02万
  • 项目类别:
Age-Related Changes in Renal Dopamine Receptor Function
肾多巴胺受体功能与年龄相关的变化
  • 批准号:
    7257008
  • 财政年份:
    2005
  • 资助金额:
    $ 21.02万
  • 项目类别:
Age-Related Changes in Renal Dopamine Receptor Function
肾多巴胺受体功能与年龄相关的变化
  • 批准号:
    6980346
  • 财政年份:
    2005
  • 资助金额:
    $ 21.02万
  • 项目类别:
Age-Related Changes in Renal Dopamine Receptor Function
肾多巴胺受体功能与年龄相关的变化
  • 批准号:
    7656746
  • 财政年份:
    2005
  • 资助金额:
    $ 21.02万
  • 项目类别:
RENAL DOPAMINE RECEPTOR FUNCTION IN OBESE ZUCKER RATS
肥胖 Zucker 大鼠肾多巴胺受体功能
  • 批准号:
    6517840
  • 财政年份:
    2001
  • 资助金额:
    $ 21.02万
  • 项目类别:
RENAL DOPAMINE RECEPTOR FUNCTION IN OBESE ZUCKER RATS
肥胖 Zucker 大鼠肾多巴胺受体功能
  • 批准号:
    6230924
  • 财政年份:
    2001
  • 资助金额:
    $ 21.02万
  • 项目类别:

相似国自然基金

DRD2/ERK/β-catenin信号联合Dopamine/ERK/TH调节环介导慢性应激促进脑胶质瘤恶性进展的研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
11C-N-CH3-Dopamine PET/MRI心脏神经显像对射血分数保留的心衰的实验研究
  • 批准号:
    82171969
  • 批准年份:
    2021
  • 资助金额:
    56 万元
  • 项目类别:
    面上项目
11C-N-CH3-Dopamine心肌Micro PET/CT显像对糖尿病心脏自主神经病变的评估
  • 批准号:
    82060323
  • 批准年份:
    2020
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目
11C-N-CH3-Dopamine神经显像对心肌"缺血记忆"的实验研究
  • 批准号:
    81460271
  • 批准年份:
    2014
  • 资助金额:
    46.0 万元
  • 项目类别:
    地区科学基金项目
11C-dopamine PET/CT显像对急性心肌缺血状况下交感神经功能变化的实验研究
  • 批准号:
    81060019
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

EFFECT OF DOPAMINE AGONISTS ON PLASMA AMINO ACIDS
多巴胺激动剂对血浆氨基酸的影响
  • 批准号:
    7203395
  • 财政年份:
    2005
  • 资助金额:
    $ 21.02万
  • 项目类别:
DOPAMINE AGONISTS AS INHIBITORS OF PROLACTIN SYNTHESIS
多巴胺激动剂作为催乳素合成抑制剂
  • 批准号:
    7180899
  • 财政年份:
    2005
  • 资助金额:
    $ 21.02万
  • 项目类别:
DOPAMINE AGONISTS AS INHIBITORS OF PROLACTIN SYNTHESIS
多巴胺激动剂作为催乳素合成抑制剂
  • 批准号:
    6976586
  • 财政年份:
    2004
  • 资助金额:
    $ 21.02万
  • 项目类别:
Inhaled dopamine agonists for late stage Parkinsonism
吸入多巴胺激动剂治疗晚期帕金森病
  • 批准号:
    6792448
  • 财政年份:
    2003
  • 资助金额:
    $ 21.02万
  • 项目类别:
Inhaled dopamine agonists for late stage Parkinsonism
吸入多巴胺激动剂治疗晚期帕金森病
  • 批准号:
    6914942
  • 财政年份:
    2003
  • 资助金额:
    $ 21.02万
  • 项目类别:
DOPAMINE AGONISTS FOR THE THERAPY OF COCAINE ADDICTION
多巴胺激动剂治疗可卡因成瘾
  • 批准号:
    6379037
  • 财政年份:
    2000
  • 资助金额:
    $ 21.02万
  • 项目类别:
DOPAMINE AGONISTS FOR THE THERAPY OF COCAINE ADDICTION
多巴胺激动剂治疗可卡因成瘾
  • 批准号:
    6310834
  • 财政年份:
    2000
  • 资助金额:
    $ 21.02万
  • 项目类别:
DOPAMINE AGONISTS AS INHIBITORS OF PROLACTIN SYNTHESIS
多巴胺激动剂作为催乳素合成抑制剂
  • 批准号:
    6120219
  • 财政年份:
    1999
  • 资助金额:
    $ 21.02万
  • 项目类别:
X RAY MODELING OF DOPAMINE AGONISTS
多巴胺激动剂的 X 射线建模
  • 批准号:
    6217783
  • 财政年份:
    1999
  • 资助金额:
    $ 21.02万
  • 项目类别:
DOPAMINE AGONISTS FOR THE THERAPY OF COCAINE ADDICTION
多巴胺激动剂治疗可卡因成瘾
  • 批准号:
    6016930
  • 财政年份:
    1999
  • 资助金额:
    $ 21.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了